BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 368012)

  • 1. Characterization of mutationally altered dihydropteroate synthase and its ability to form a sulfonamide-containing dihydrofolate analog.
    Swedberg G; Castensson S; Sköld O
    J Bacteriol; 1979 Jan; 137(1):129-36. PubMed ID: 368012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonamide resistance mechanism in Escherichia coli: R plasmids can determine sulfonamide-resistant dihydropteroate synthases.
    Wise EM; Abou-Donia MM
    Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2621-5. PubMed ID: 1101260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free dihydropteroate synthetase activity: its use to investigate the relationship between structure and activity of p-aminobenzoic derivatives.
    Thijssen HH
    Methods Enzymol; 1980; 66():570-6. PubMed ID: 6990197
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of a mutationally altered dihydropteroate synthase contributing to sulfathiazole resistance in Escherichia coli.
    Vedantam G; Nichols BP
    Microb Drug Resist; 1998; 4(2):91-7. PubMed ID: 9650994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R-factor-mediated resistance to sulfonamides by a plasmid-borne, drug-resistant dihydropteroate synthase.
    Sköld O
    Antimicrob Agents Chemother; 1976 Jan; 9(1):49-54. PubMed ID: 769673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.
    Lever OW; Bell LN; McGuire HM; Ferone R
    J Med Chem; 1985 Dec; 28(12):1870-4. PubMed ID: 3906132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of different plasmid-borne dihydropteroate synthases mediating bacterial resistance to sulfonamides.
    Swedberg G; Sköld O
    J Bacteriol; 1980 Apr; 142(1):1-7. PubMed ID: 6989796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase.
    Roland S; Ferone R; Harvey RJ; Styles VL; Morrison RW
    J Biol Chem; 1979 Oct; 254(20):10337-45. PubMed ID: 385600
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
    Achari A; Somers DO; Champness JN; Bryant PK; Rosemond J; Stammers DK
    Nat Struct Biol; 1997 Jun; 4(6):490-7. PubMed ID: 9187658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.
    McCullough JL; Maren TH
    Antimicrob Agents Chemother; 1973 Jun; 3(6):665-9. PubMed ID: 4597736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effectiveness with which p-aminobenzoic acid and p-aminobenzoylglutamic acid are used as substrate by dihydropteroate synthetase from Escherichia coli.
    Richey DP; Brown GM
    Biochim Biophys Acta; 1970 Oct; 222(1):237-9. PubMed ID: 4919883
    [No Abstract]   [Full Text] [Related]  

  • 12. Catalysis and sulfa drug resistance in dihydropteroate synthase.
    Yun MK; Wu Y; Li Z; Zhao Y; Waddell MB; Ferreira AM; Lee RE; Bashford D; White SW
    Science; 2012 Mar; 335(6072):1110-4. PubMed ID: 22383850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.
    Lever OW; Bell LN; Hyman C; McGuire HM; Ferone R
    J Med Chem; 1986 May; 29(5):665-70. PubMed ID: 3486292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of random mutations in Salmonella Gallinarum dihydropteroate synthase conferring sulfonamide resistance.
    Duysak T; Jeong JH; Kim K; Kim JS; Choy HE
    Arch Microbiol; 2023 Oct; 205(12):363. PubMed ID: 37906281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme.
    Lopez P; Espinosa M; Greenberg B; Lacks SA
    J Bacteriol; 1987 Sep; 169(9):4320-6. PubMed ID: 3114239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.
    Valderas MW; Andi B; Barrow WW; Cook PF
    Biochim Biophys Acta; 2008 May; 1780(5):848-53. PubMed ID: 18342015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding Isotope Effects for para-Aminobenzoic Acid with Dihydropteroate Synthase from Staphylococcus aureus and Plasmodium falciparum.
    Stratton CF; Namanja-Magliano HA; Cameron SA; Schramm VL
    ACS Chem Biol; 2015 Oct; 10(10):2182-6. PubMed ID: 26288086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
    Thijssen HH
    J Med Chem; 1977 Feb; 20(2):233-6. PubMed ID: 319235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Dihydropteroate Synthase-Based Fluorescence Polarization Assay for Detection of Sulfonamides and Studying Its Recognition Mechanism.
    He T; Liu J; Wang JP
    J Agric Food Chem; 2021 Nov; 69(46):13953-13963. PubMed ID: 34783550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
    Vinnicombe HG; Derrick JP
    Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.